Variant report
Variant | esv3346016 |
---|---|
Chromosome Location | chr4:48317895-48319943 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:48271185..48273592-chr4:48315743..48318601,2 | K562 | blood: | |
2 | chr4:48129577..48130360-chr4:48317760..48318680,2 | K562 | blood: | |
3 | chr4:48306231..48309120-chr4:48316707..48318275,2 | K562 | blood: | |
4 | chr4:48317545..48320000-chr4:48323485..48325753,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000135605 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554513154 | chr4:48317896-48317897 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs548431300 | chr4:48317922-48317923 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs139307823 | chr4:48317940-48317941 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs533777006 | chr4:48317941-48317942 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs558704296 | chr4:48317944-48317945 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs577228000 | chr4:48317976-48317977 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs7665958 | chr4:48318068-48318069 | Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs373502240 | chr4:48318079-48318080 | Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs574446563 | chr4:48318103-48318104 | Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs35655265 | chr4:48318138-48318139 | Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs369964509 | chr4:48318173-48318174 | Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs75677507 | chr4:48318177-48318178 | Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs149998428 | chr4:48318181-48318182 | Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs572091429 | chr4:48318182-48318183 | Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs145241665 | chr4:48318199-48318200 | Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs556109688 | chr4:48318224-48318225 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs376286252 | chr4:48318238-48318239 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs62309395 | chr4:48318252-48318253 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs565107231 | chr4:48318258-48318259 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs532667947 | chr4:48318261-48318262 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs550818830 | chr4:48318268-48318269 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs562830998 | chr4:48318283-48318284 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs553004004 | chr4:48318293-48318294 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs192870448 | chr4:48318331-48318332 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs548544922 | chr4:48318336-48318337 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs566889095 | chr4:48318350-48318351 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs185341518 | chr4:48318387-48318388 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs4599384 | chr4:48318390-48318391 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs190273685 | chr4:48318393-48318394 | Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs7666809 | chr4:48318489-48318490 | Flanking Active TSS Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs556538749 | chr4:48318494-48318495 | Flanking Active TSS Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs141262123 | chr4:48318501-48318502 | Flanking Active TSS Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs144962277 | chr4:48318521-48318522 | Flanking Active TSS Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs181930489 | chr4:48318593-48318594 | Flanking Active TSS Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 22522925 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:48318000-48318200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr4:48318000-48318400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr4:48318000-48318400 | Enhancers | NH-A | brain |
4 | chr4:48318000-48318600 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
5 | chr4:48318200-48318400 | Enhancers | Psoas Muscle | Psoas |
6 | chr4:48318200-48318400 | Enhancers | Osteobl | bone |
7 | chr4:48318200-48318600 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr4:48318200-48318600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
9 | chr4:48318200-48318600 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr4:48318200-48318600 | Enhancers | Adipose Nuclei | Adipose |
11 | chr4:48318200-48318600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
12 | chr4:48318200-48318600 | Enhancers | NHLF | lung |